Correction: Clinical Epigenetics (2019) 11:68 https://doi.org/10.1186/s13148-019-0663-8
Figure 6 of the original publication [1] contained a picture duplication in the U-937 panel resulting from an error while copy/pasting the individual pictures used to prepare the figure. The erroneous picture panel did not affect the corresponding quantification of cell death and the interpretation of the results as it was done with the correct picture set. The corrected Fig. 6 is presented in this correction.
Nuclear morphology analysis in U-937, RAJI, KG-1, and RPMI1788 cells. Cells were treated with increasing doses of MC3353. Upper panels—after 72 h of treatment, the nuclear morphology was analyzed by fluorescence microscopy after Hoechst and PI staining. Pictures are representative of three independent experiments. Lower panels—results of cell counting are represented as the mean (± SD) of three independent experiments
Reference
Zwergel C, Schnekenburger M, Sarno F, Battistelli C, Manara MC, Stazi G, Mazzone R, Fioravanti R, Gros C, Ausseil F, et al. Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells. Clin Epigenetics. 2019;11(1):68. https://doi.org/10.1186/s13148-019-0663-8.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Zwergel, C., Schnekenburger, M., Sarno, F. et al. Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells. Clin Epigenet 14, 119 (2022). https://doi.org/10.1186/s13148-022-01339-y
Published:
DOI: https://doi.org/10.1186/s13148-022-01339-y